PlatformQ Health is pleased to announce a three-part educational series for the clinicians treating and families facing multiple sclerosis (MS), created in collaboration with the National Multiple Sclerosis Society (NMSS) and the Consortium of Multiple Sclerosis Centers (CMSC).

On June 20, 2019, two special programs will be streamed live – one created especially for clinicians, which will be available on NeuroSeriesLive, and the other designed for patients and families facing MS, which will be available on NeuroCareLive, a website specifically for patients with neurological diseases.

  • At 10am ET, clinicians will be able to access Current Management of Early to Relapsing Forms of Multiple Sclerosis: A Comprehensive Approach to earn AMA PRA Category 1 Credit™ and learn about the accumulated clinical evidence, current guidelines, and emerging new clinical data into individualized selection of DMTs for MS as part of a comprehensive approach to management that includes SDM with patients, ongoing monitoring, and DMT optimization. Speakers include representatives from Johns Hopkins School of Medicine, Georgetown University, and Loyola Medicine.
  • At 1pm ET, NMSS representatives will join clinical specialists and people who live with MS for Living with Multiple Sclerosis: From Diagnosis to Initial Treatment and Relapse Management. In the live premier, clinician, advocacy and patient panelists will answer questions from learners and discuss topics including what happens after being diagnosed, what to expect in terms of periods of stability and relapses, mental health and self-care, and where to go for support and additional resources. Interested parties can save a seat to attend this free patient and caregiver program live, or receive access to the on-demand presentation, here.

On July 27, 2019 at 11am ET, clinicians and affected families are invited to a joint session, Working Together to Address Challenges in Multiple Sclerosis Care: A Collaborative Dialogue. PlatformQ Health believes firmly in the value of aligned education, and has found outcomes in other therapeutic areas that suggest teaching clinicians, patients, and caregivers yields better outcomes – but this will mark the first time that the organization has designed a joint activity for both clinicians and families.

“We are excited to provide a combined session for people personally facing MS and the clinicians who treat this condition in an easy-to-access environment,” shared Anne Roc, PlatformQ Health’s Vice President of Medical Education. “Over the course of a patient’s journey, patients and family members become experts-by-experience, and the average familiarity with the condition is strong enough that we can present information at a level that is appropriate both for those families and for healthcare professionals. The presence of both parties at the table provides the opportunity to address misinformation, misperceptions and communication barriers. This is a powerful resource for patients and their families, and for clinicians to work more effectively with their patients.”

“At the same time, the field of MS is constantly evolving so while knowledge improves over time, new questions continue to come up,” added Wendy Turell, VP of Outcomes & Analytics. “This session will meet this community’s specific needs, while helping clinicians better understand the lived experience of their patients.”

To learn more about how PlatformQ Health designs impactful education for patients, caregivers, and clinicians, please contact Lauren Alford.